Ligand Pharmaceuticals
LGND
LGND
275 hedge funds and large institutions have $2.32B invested in Ligand Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 75 increasing their positions, 130 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
275
Holders Change
-30
Holders Change %
-9.84%
% of All Funds
6.04%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
21
Increased
75
Reduced
130
Closed
50
Calls
$36.6M
Puts
$200M
Net Calls
-$163M
Net Calls Change
-$133M
Top Buyers
Top Sellers
1 |
Invesco
Atlanta,
Georgia
|
-$33.6M |
2 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$20.9M |
3 |
Goldman Sachs
New York
|
-$20.3M |
4 |
Victory Capital Management
San Antonio,
Texas
|
-$17.8M |
5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$17.2M |